PPA
KRTX

Parametric Portfolio Associates’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Parametric Portfolio Associates’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$478K Sell
3,767
-1,949
-34% -$219K ﹤0.01% 3115
2021
Q4 		$749K Sell
5,716
-379
-6% -$49K ﹤0.01% 2904
2021
Q3 		$746K Buy
6,095
+430
+8% +$49.6K ﹤0.01% 2930
2021
Q2 		$646K Sell
5,665
-139
-2% -$16.2K ﹤0.01% 2978
2021
Q1 		$698K Buy
5,804
+2,535
+78% +$287K ﹤0.01% 3330
2020
Q4 		$332K Buy
+3,269
New +$303K ﹤0.01% 3553
2020
Q3 		– Sell
-10,178
Closed -$1.13M – 3983
2020
Q2 		$1.13M Sell
10,178
-2,016
-17% -$175K ﹤0.01% 2850
2020
Q1 		$878K Sell
12,194
-2,877
-19% -$246K ﹤0.01% 2874
2019
Q4 		$1.14M Buy
+15,071
New +$660K ﹤0.01% 3003

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return